Addex Total Liabilities vs Cash and Equivalents Analysis
ADXN Stock | USD 20.96 1.04 4.73% |
Trend analysis of Addex Therapeutics balance sheet accounts such as Short Long Term Debt Total of 461.9 K, Other Current Liabilities of 1.5 M or Total Current Liabilities of 4.1 M provides information on Addex Therapeutics' total assets, liabilities, and equity, which is the actual value of Addex Therapeutics to its prevalent stockholders. By breaking down trends over time using Addex Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Addex |
About Addex Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Addex Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Addex Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Addex Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Addex currently owns. An asset can also be divided into two categories, current and non-current.
Addex Therapeutics Balance Sheet Chart
Addex Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Addex Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Addex Therapeutics' Total Liabilities is very stable compared to the past year. As of the 19th of April 2024, Intangible Assets is likely to grow to about 30.8 M, while Total Assets are likely to drop about 7.1 M. Add Fundamental
Total Assets
Total assets refers to the total amount of Addex Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Addex Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Additional Paid In Capital
Additional Paid In Capital (or APIC) is an accounting term found on Addex Therapeutics Balance Sheet under Shareholders Equity. It is the value of the shares of the company above what they were issued it. The basic calculation is as follow: (Issue Price - Par Value) x Addex Therapeutics Shares Outstanding. Additional Paid In Capital is not affected by secondary trading of Addex Therapeutics shares and does not have any impact on the value of APIC. The excess amount paid by investors over the par value of a company’s shares, representing the additional capital contributed by shareholders.Most indicators from Addex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Addex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.As of the 19th of April 2024, Enterprise Value is likely to grow to about 554.8 M, while Selling General Administrative is likely to drop about 4.3 M.
Addex Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Addex Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Addex Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 33.0M | 20.2M | 22.5M | 8.3M | 7.5M | 7.1M | |
Other Current Liab | 2.0M | 1.5M | 2.1M | 1.7M | 1.5M | 1.5M | |
Total Current Liabilities | 5.7M | 3.6M | 4.1M | 3.3M | 3.0M | 4.1M | |
Total Stockholder Equity | 25.5M | 14.6M | 16.9M | 4.9M | 4.4M | 4.2M | |
Property Plant And Equipment Net | 571.0K | 633.1K | 542.1K | 398.7K | 358.9K | 340.9K | |
Net Debt | (31.0M) | (18.1M) | (20.0M) | (6.6M) | (7.6M) | (8.0M) | |
Retained Earnings | (300.8M) | (313.7M) | (329.1M) | (349.9M) | (314.9M) | (330.6M) | |
Accounts Payable | 2.2M | 983.5K | 1.8M | 1.3M | 1.1M | 923.5K | |
Cash | 31.5M | 18.7M | 20.5M | 7.0M | 6.3M | 5.9M | |
Non Current Assets Total | 639.9K | 692.2K | 600.0K | 453.1K | 407.8K | 387.4K | |
Non Currrent Assets Other | 68.9K | 59.1K | 57.9K | 54.4K | 48.9K | 46.5K | |
Cash And Short Term Investments | 31.6M | 18.8M | 20.5M | 7.0M | 6.3M | 6.0M | |
Common Stock Shares Outstanding | 26.4M | 26.7M | 34.1M | 45.2M | 52.0M | 54.6M | |
Liabilities And Stockholders Equity | 33.0M | 20.2M | 22.5M | 8.3M | 7.5M | 7.1M | |
Other Current Assets | 734.0K | 498.4K | 1.1M | 871.9M | 1.0B | 1.1B | |
Other Stockholder Equity | 286.4M | 286.9M | 272.3M | 327.9M | 377.0M | 284.2M | |
Total Liab | 7.5M | 5.6M | 5.6M | 3.4M | 3.0M | 4.6M | |
Property Plant And Equipment Gross | 571.0K | 633.1K | 4.3M | 4.4M | 4.0M | 2.4M | |
Total Current Assets | 32.4M | 19.5M | 21.9M | 7.8M | 7.0M | 6.7M | |
Short Term Debt | 373.0K | 308.6K | 287.7K | 286.1K | 329.0K | 181.4K | |
Non Current Liabilities Total | 1.8M | 2.0M | 1.5M | 87.0K | 100.1K | 95.1K | |
Accumulated Other Comprehensive Income | 7.1M | 8.6M | 24.4M | 25.8M | 29.6M | 31.1M | |
Net Receivables | 118.0K | 68.4K | 324.4K | 598.3K | 538.5K | 285.4K | |
Other Liab | 639.4K | 1.6M | 1.7M | 1.3M | 1.5M | 813.2K | |
Net Tangible Assets | 25.5M | 14.6M | 16.9M | 4.9M | 5.6M | 5.4M | |
Other Assets | 68.9K | 59.1K | 57.9K | 54.4K | 48.9K | 66.0K | |
Short Term Investments | 14.0K | 64.9K | 17.1K | 3.2K | 3.6K | 3.5K | |
Property Plant Equipment | 571.0K | 633.1K | 542.1K | 398.7K | 458.5K | 275.1K | |
Net Invested Capital | 25.5M | 14.6M | 16.9M | 4.9M | 4.4M | 4.2M | |
Net Working Capital | 26.7M | 15.9M | 17.8M | 4.5M | 4.1M | 3.9M |
Pair Trading with Addex Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Addex Stock
0.85 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
0.63 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
0.42 | KZR | Kezar Life Sciences Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Addex Stock analysis
When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.74) | Revenue Per Share 3.72 | Quarterly Revenue Growth (0.21) | Return On Assets (0.75) | Return On Equity (1.91) |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.